REGENERON PHARMACEUTICALS
REGNNASDAQ$749.10▼ $3.15 (−0.42%)
LiveTrack REGN
Get earnings, price moves & breaking news on Telegram
24h▼ 0.4%
7d▼ 6.8%
14d▼ 3.2%
30d▼ 5.7%
ytd▼ 2.9%
1y▲ 33.6%
🏦Market Cap
$77.17B
Mid Cap
📈Revenue Growth (YoY)
+1.0%
Slowing
📊Gross Margin
84.9%
High
💵FCF Margin
22.7%
Strong
⚖️P/S Ratio
5.0x
Fair
Otter Score
72
Fair
REGENERON PHARMACEUTICALS
REGNAnalyst Ratings
Price
$749.10
Total
49
Raised
8
Lowered
3
Avg PT
$827.71
H / L
$1030 / $730
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
RBC Capital | Reiterated | Sector Perform | 2026-09-29 | $737.00 | −1.60% |
HSBC | Reiterated | Buy | 2026-09-10 | $920.00 | +22.80% |
Leerink Partners | Reiterated | Market Perform | 2026-08-17 | $824.00 | +10.00% |
Guggenheim | Reiterated | Buy | 2026-08-03 | $1030.00 | +37.50% |
Citigroup | Reiterated | Neutral | 2026-08-03 | $650.00 | −13.20% |
Truist Securities | Reiterated | Buy | 2026-07-31 | — | — |
Morgan Stanley | Reiterated | Equal Weight | 2026-07-31 | $758.00 | +1.20% |
Cantor Fitzgerald | Reiterated | Overweight | 2026-07-31 | $795.00 | +6.10% |
Wells Fargo | Reiterated | Equal Weight | 2026-07-31 | $750.00 | +0.10% |
Piper Sandler | Reiterated | Overweight | 2026-07-09 | $854.00 | +14.00% |
Benchmark | Upgraded | Hold → Buy | 2026-07-07 | — | — |
Canaccord Genuity | Reiterated | Buy | 2026-05-19 | $875.00 | +16.80% |
BMO Capital | Reiterated | Outperform | 2026-05-18 | $730.00 | −2.50% |
JP Morgan | Reiterated | Overweight | 2026-05-18 | — | — |
Barclays | Reiterated | Overweight | 2026-04-30 | $917.00 | +22.40% |
TD Cowen | Reiterated | Buy | 2026-04-23 | — | — |
Bernstein | Reiterated | Outperform | 2026-04-08 | $756.00 | +0.90% |
Oppenheimer | Reiterated | Outperform | 2026-02-02 | $865.00 | +15.50% |
Evercore ISI Group | Reiterated | Outperform | 2026-01-22 | — | — |
B of A Securities | Upgraded | Underperform → Buy | 2026-01-07 | — | — |
Scotiabank | Reiterated | Sector Perform | 2025-11-24 | $770.00 | +2.80% |
UBS | Reiterated | Neutral | 2025-11-07 | $584.00 | −22.00% |
Jefferies | Reiterated | Buy | 2025-08-27 | — | — |
Baird | Reiterated | Neutral | 2025-04-30 | — | — |
Goldman Sachs | Reiterated | Buy | 2025-04-30 | $914.00 | +22.00% |
Argus Research | Reiterated | Buy | 2024-06-25 | $1170.00 | +56.20% |
Raymond James | Upgraded | Market Perform → Outperform | 2023-11-03 | $910.00 | +21.50% |
EF Hutton | Reiterated | Buy | 2023-05-01 | — | — |
SVB Leerink | Upgraded | Market Perform → Outperform | 2023-03-27 | — | — |
Cowen & Co. | Upgraded | Market Perform → Outperform | 2023-01-30 | — | — |
HC Wainwright & Co. | Reiterated | Buy | 2021-11-05 | — | — |
Credit Suisse | Reiterated | Outperform | 2021-02-23 | — | — |
SunTrust Robinson Humphrey | Upgraded | Hold → Buy | 2020-07-09 | — | — |
CFRA | Reiterated | Hold | 2020-05-27 | — | — |
Argus | Downgraded | Buy → Hold | 2019-06-18 | — | — |
Leerink Swann | Reiterated | Outperform | 2018-02-09 | — | — |
BTIG | Downgraded | Buy → Neutral | 2018-02-09 | — | — |
BTIG Research | Downgraded | Buy → Neutral | 2018-02-09 | — | — |
Deutsche Bank | Reiterated | Hold | 2017-12-13 | — | — |
PiperJaffray | Upgraded | Neutral → Overweight | 2017-02-13 | — | — |
Chardan Capital | Upgraded | Sell → Neutral | 2016-12-12 | — | — |
Roth Capital | Reiterated | Buy | 2016-04-04 | — | — |
Gabelli & Co. | Reiterated | Buy | 2016-03-15 | — | — |
Brean Capital | Reiterated | Buy | 2016-02-10 | — | — |
Bank of America | Reiterated | Buy | 2014-11-21 | — | — |
Argus Capital | Reiterated | Buy | 2014-07-21 | — | — |
Lazard | Reiterated | Buy | 2013-09-13 | — | — |
JMP Securities | Reiterated | Market Perform → Perform | 2013-03-28 | — | — |
Bank oferica | Reiterated | Buy | 2012-05-29 | — | — |
Institution
RBC Capital
Reiterated · Sector Perform · 2026-09-29
$737.00
−1.60%
HSBC
Reiterated · Buy · 2026-09-10
$920.00
+22.80%
Leerink Partners
Reiterated · Market Perform · 2026-08-17
$824.00
+10.00%
Guggenheim
Reiterated · Buy · 2026-08-03
$1030.00
+37.50%
Citigroup
Reiterated · Neutral · 2026-08-03
$650.00
−13.20%
Truist Securities
Reiterated · Buy · 2026-07-31
—
—
Morgan Stanley
Reiterated · Equal Weight · 2026-07-31
$758.00
+1.20%
Cantor Fitzgerald
Reiterated · Overweight · 2026-07-31
$795.00
+6.10%
Wells Fargo
Reiterated · Equal Weight · 2026-07-31
$750.00
+0.10%
Piper Sandler
Reiterated · Overweight · 2026-07-09
$854.00
+14.00%
Benchmark
Upgraded · Hold → Buy · 2026-07-07
—
—
Canaccord Genuity
Reiterated · Buy · 2026-05-19
$875.00
+16.80%
BMO Capital
Reiterated · Outperform · 2026-05-18
$730.00
−2.50%
JP Morgan
Reiterated · Overweight · 2026-05-18
—
—
Barclays
Reiterated · Overweight · 2026-04-30
$917.00
+22.40%
TD Cowen
Reiterated · Buy · 2026-04-23
—
—
Bernstein
Reiterated · Outperform · 2026-04-08
$756.00
+0.90%
Oppenheimer
Reiterated · Outperform · 2026-02-02
$865.00
+15.50%
Evercore ISI Group
Reiterated · Outperform · 2026-01-22
—
—
B of A Securities
Upgraded · Underperform → Buy · 2026-01-07
—
—
Scotiabank
Reiterated · Sector Perform · 2025-11-24
$770.00
+2.80%
UBS
Reiterated · Neutral · 2025-11-07
$584.00
−22.00%
Jefferies
Reiterated · Buy · 2025-08-27
—
—
Baird
Reiterated · Neutral · 2025-04-30
—
—
Goldman Sachs
Reiterated · Buy · 2025-04-30
$914.00
+22.00%
Argus Research
Reiterated · Buy · 2024-06-25
$1170.00
+56.20%
Raymond James
Upgraded · Market Perform → Outperform · 2023-11-03
$910.00
+21.50%
EF Hutton
Reiterated · Buy · 2023-05-01
—
—
SVB Leerink
Upgraded · Market Perform → Outperform · 2023-03-27
—
—
Cowen & Co.
Upgraded · Market Perform → Outperform · 2023-01-30
—
—
HC Wainwright & Co.
Reiterated · Buy · 2021-11-05
—
—
Credit Suisse
Reiterated · Outperform · 2021-02-23
—
—
SunTrust Robinson Humphrey
Upgraded · Hold → Buy · 2020-07-09
—
—
CFRA
Reiterated · Hold · 2020-05-27
—
—
Argus
Downgraded · Buy → Hold · 2019-06-18
—
—
Leerink Swann
Reiterated · Outperform · 2018-02-09
—
—
BTIG
Downgraded · Buy → Neutral · 2018-02-09
—
—
BTIG Research
Downgraded · Buy → Neutral · 2018-02-09
—
—
Deutsche Bank
Reiterated · Hold · 2017-12-13
—
—
PiperJaffray
Upgraded · Neutral → Overweight · 2017-02-13
—
—
Chardan Capital
Upgraded · Sell → Neutral · 2016-12-12
—
—
Roth Capital
Reiterated · Buy · 2016-04-04
—
—
Gabelli & Co.
Reiterated · Buy · 2016-03-15
—
—
Brean Capital
Reiterated · Buy · 2016-02-10
—
—
Bank of America
Reiterated · Buy · 2014-11-21
—
—
Argus Capital
Reiterated · Buy · 2014-07-21
—
—
Lazard
Reiterated · Buy · 2013-09-13
—
—
JMP Securities
Reiterated · Market Perform → Perform · 2013-03-28
—
—
Bank oferica
Reiterated · Buy · 2012-05-29
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space